DB05145ExperimentalProtein Based Therapies
TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the treatment of type 2 diabetes.
- Primary indication
- Investigated for use/treatment in diabetes mellitus type 1 and 2.Curator reviewed
- Also known as
- ThGLP-1
- Code names
- TH0318
Which companies are running trials of TH0318, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account